Skip to main content

Designer immune cells

Guest edited by Naoki Hosen, Osaka University, Japan

A thematic series in Inflammation and Regeneration.

This series of articles has not been sponsored. All articles have undergone the journal's standard peer review process overseen by the Guest Editor. The Guest Editor declares no competing interests.

  1. In recent years, immunotherapy has become a standard cancer therapy, joining surgery, chemotherapy, and radiation therapy. This therapeutic approach involves the use of patient-derived antigen-specific T cells or...

    Authors: Sota Kurihara, Akihiro Ishikawa and Shin Kaneko
    Citation: Inflammation and Regeneration 2024 44:20
    Content type: Review Published on:

  4. Cancer cell therapy, particularly chimeric antigen receptor (CAR) T-cell therapy for blood cancers, has emerged as a powerful new modality for cancer treatment. Therapeutic cells differ significantly from conv...

    Authors: Noyuri Zama and Satoshi Toda
    Citation: Inflammation and Regeneration 2024 44:15
    Content type: Review Published on: